Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity

Journal of Pharmaceutical Sciences

Volumn 97, Issue 8, 2008, Pages 3195-3206

  Sousa, Célia ^a   Nunes, Cláudia ^a   Lúcio, Marlene ^a   Ferreira, Helena ^a   Lima, José L F C ^a   Tavares, Joana ^b   Cordeiro Da Silva, Anabela ^b   Reis, Salette ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Drug interactions; Fluorescence spectroscopy; In vitro models; Liposomes; NSAID

Indexed keywords

LORNOXICAM; MELOXICAM; NIMESULIDE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN;

EID: 52449124711     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21218     Document Type: Article

References (51)

1. Vane JR, Dotting RM. 1995. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 44:1-10.
2. Rang HP, Dale MM, Ritter JM. 1999. Pharmacology. 4th edition. London: Churchill Livingstone.
3. Beccerica E, Piergiacomi G, Curatola G, Ferretti G. 1989. Effect of antirheumatic drugs on lymphocyte membrane fluidity in rheumatoid arthritis: A fluorescence polarization study. Pharmacology 38: 16-22.
4. Lamche H, Silberstein PT, Knabe AC, Thomas DD, Jacob HS, Hammerschmidt HSJ. 1990. Steroids decrease granulocyte membrane fluidity, while phorbol ester increases membrane fluidity. Studies using electron paramagnetic resonance. Inflammation 14:61-70.
5. Goldsby RA, Kindt T, Osborne BA, Kuby J. 2003. Immunology. 5th edition. New York: W. H. Freeman and Company.
6. Fendler JH. 1980. Microemulsions, micelles, and vesicles as media for membrane mimetic photo chemistry. J Phys Chem 84:1485-1491.
7. Fendler JH. 1983. Membrane mimetic chemistry, 1st ed. New York: John Wiley & Sons.
8. Lúcio M, Ferreira H, Lima JLFC, Matos C, Castro B, Reis S. 2004. Influence of some anti-inflammatory drugs in membrane fluidity studied by fluorescence anisotropy measurements. PCCP 6:1493-1498.
9. Wang S, Beechem JM, Gratton E, Glaser M. 1991. Orientational distribution of 1,6-diphenyl-1,3,5-hexatriene in phospholipid vesicles as determined by global analysis of frequency domain fluorimetry data. Biochemistry 30:5512-5565.
10. Kaiser RD, London E. 1998. Location of diphenyl-hexatriene (DPH) and its derivatives within membranes: Comparison of different fluorescence quenching analysis of membrane depth. Biochemistry 37:8180-8190.
11. Repáková J, Holopainen JM, Morrow MR, McDonald MC, Capková P, Vattulainen I, 2005. Influence of DPH on the structure and dynamics of a DPPC bilayer. Biophys J 88:3398-3410.
12. Knazek RA, Liu SC, Dave JR, Christy RJ, Keller JA. 1981. Indomethacin causes a simultaneous decrease of both prolactin binding and fluidity of mouse liver membranes. Prostaglandins Med 6:403-411.
13. Brailoiu E, Margineanu A, Miyamoto MD. 1998. Angiotensin II and related peptides alter liposomal membrane fluidity. Biochem Mol Biol Int 44:203-209.
14. Giraud MN, Motta C, Romero JJ, Bommelaer G, Lichtenberger LM. 1999. Interaction of Indomethacin and Naproxen with gastic surface-active phospholipids: A possible mechanism for the gastric toxicity of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Biochem Pharmacol 57:247-254.
15. Ligumsky M, Golanska EM, Hansen DG, Kauffman GJ. 1983. Aspirin can inhibit gastric mucosal cyclooxygenase without causing lesions in rat. Gastroenterology 84:756-761.
16. Lasic DD. 1993. Liposomes - From physics to applications, 1st ed. New York: Elsevier.
17. McClare CWF. 1971. An accurate and convenient organic phosphorus assay. Anal Biochem 39:527-530.
18. Borges M, Guilvard E, Cordeiro da Silva A, Vergnes B, Zemzoumi K, Ouaissi A. 2001. Endogenous Trypanosoma cruzi Tc52 protein expression upregulates the growth murine macrophages and fibroblastes and cytokine gene expression. Immunol Lett 39: 127-134.
19. Sereno D, Guilvard E, Maquaire S, Cavaleyra M, Holzmuller P, Ouaissi A, Lemesre JL. 2001. Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: Implications for the spread of chemoresistance in endemic areas. Acta Tropica 80:195-205.
20. Lentz BR. 1989. Membrane fluidity as detected by diphenylhexatriene probes. Chem Phys Lipids 50: 171-190.
21. Shinitzky M, Barenholz Y. 1978. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta 515:367-394.
22. Kuhry JG, Duportail G, Bronner C, Laustriat G. 1985. Plasma membrane fluidity measurements on whole living cells by fluorescence anisotropy of trimethylammoniumdiphenylhexatriene. Biochim Biophys Acta 845:60-67.
23. Kiselev MA, Leslour P, Kisseley AM, Grablel-Madelmond C, Ollivon M. 1999. DMSO-induced dehydration of DPPC membranes studied by X-ray diffraction, small-angle neutron scattering, and calorimetry. J Alloys Coumpd 286:195-202.
24. Lúcio M, Ferreira H, Lima JLFC, Reis S. 2006. Interactions between oxicams and membrane bilayers: An explanation for their different COX selectivity. Med Chem 2:447-456.
25. Chalpin DB, Kleinfeld AM. 1983. Interaction of fluorescence quenchers with the n-(9-anthroyloxy) fatty acid membrane probes. Biochim Biophys Acta 731:465-474.
26. New RRC. 1990. Liposomes - A practical approach, 1st ed. New York: Oxford University Press.
27. Lentz BR. 1993. Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. Chem Phys Lipids 64:99-116.
28. Lakowicz JR. 1999. Principles of Fluorescence Spectroscopy. 2nd edition. New York: Kluwer Academic/ Plenum Press.
29. Santos NC, Prieto M, Castanho MA. 1998. Interaction of major epitope region of HIV protein gp41 with membrane model systems. A fluorescence spectroscopy study. Biochemistry 37:8674-8682.
30. Davenport L, Dale RE, Bisby RH, Cundall RB. 1985. Transverse location of the fluorescent probe l,6-diphenyl-1,3,5-hexatriene in model lipid bilayer membrane systems by resonance excitation energy transfer. Biochemistry 24:4097-4108.
31. Kintanar A, Kunwar AC, Oldfield E. 1986. Deuterium nuclear magnetic resonance spectroscopic study of the fluorescent probe diphenylhexatriene in model membrane systems. Biochemistry 25: 6517-6524.
32. Mitchell DC, Litman BJ. 1998. Molecular order and dynamics in bilayers consisting of highly poly-unsaturated phospholipids. Biophys J 74:879-891.
33. Mulders F, van Langen H, van Ginkel G, Levine YK. 1986. The static and dynamic behaviour of fluorescent probe molecules in lipid bilayers. Bio-chim Biophys Acta 859:209-218.
34. Pap EHW, ter Horst JJ, van Hoek A, Visser AJWG. 1994. Fluorescence dynamics of diphenyl-1,3, 5-hexatriene-labeled phospholipids in bilayer membranes. Biophys Chem 48:337-351.
35. Repáková J, Capková P, Holopainen JM, Vattulainen I, 2004. Distribution, orientation, and dynamics of DPH probes in DPPC bilayer. J Phys Chem B 108: 13438-13448.
36. Grossman CJ, Wiseman J, Lucas FS, Trevethick MA, Birch PJ. 1995. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors. Inflamm Res 44:253-257.
37. Pellicanò A, Sebkova L, Monteleone G, Guarnieri G, Imeneo M, Pallone F, Luzza F. 2007. Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected Human gastric mucosa. Infect Immun 75:1738-1744.
38. Radhofer-Welte S, Rabasseda X. 2000. Lornoxicam, a new potent NSAID with an improved tolerability profile. Drugs Today 36:55-76.
39. Vane JR, Botting J, Botting RM. 1996. Improved nonsteroidal anti inflammatory drugs-COX-2 enzyme inhibitors, 1st ed. London: Kluwer Academic Publishers.
40. Ren J, Lew S, Wang Z, London E. 1997. Transmembrane orientation of hydrophobic-helices is regulated both by the relationship of helix length to bilayer thickness and by the cholesterol concentration. Biochemistry 36:10213-10220.
41. Williams BW, Scotto AW, Stubbs CD. 1990. Effect of proteins on fluorophore lifetime heterogeneity in lipid bilayers. Biochemistry 29:3248-3255.
42. Tricerri MA, Garda HA, Brenner RR. 1994. Lipid chain order and dynamics at different bilayer depths in liposomes of several phosphatidylcholines studied by differential polarized phase fluorescence. Chem Phys Lipids 71:61-72.
43. Parasassi T, De Stasio G, Rusch RM, Gratton E. 1991. A photophysical model for diphenylhexatriene fluorescence decay in solvents and in phospholipid vesicles. Biophys J 59:466-475.
44. Kutchai H, Chandler L, Zavoico GB. 1983. Effects of cholesterol on acyl chain dynamics in multilamellar vesicles of various phosphatidylcholines. Biochim Biophys Acta 736:137-149.
45. Macdonald AG, Wahle KWJ, Cossins AR, Behan MK. 1988. Temperature, pressure and cholesterol effects on bilayer fluidity; a comparison of pyrene excimer/monomer ratios with the steady-state fluorescence polarization of diphenylhexatriene in liposomes and microsomes. Biochim Biophys Acta 938:231-242.
46. Phillips MC. 1972. The physical state of phospholipids and cholesterol in monolayers, bilayers, and membranes. Prog Surf Membr Sci 5:139-221.
47. Lentz BR, Barrow DA, Hoechli M. 1980. Cholesterol-phosphatidylcholine interactions in multilamellar vesicles. Biochemistry 19:1943-1954.
48. Nair P, Kanwar SS, Sanyal SN. 2006. Effects of non steroidal anti-inflammatory drugs on the antioxidant defense system and the membrane functions in the rat intestine. Nutr Hosp 21:638-649.
49. Gennaro AR. 2000. Non steroidal antiinflammatory drugs, 20th ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins.
50. Horan KL, Lutzke BS, Cazers AR, McCall JM, Epps DE. 1994. Kinetic evaluation of lipophilic inhibitors of lipid peroxidation in DLPC liposomes. Free Radic Biol Med 17:587-596.
51. Sanyal SN, Sood N, Kaushal N. 2006. Alterations in the lipid profile and membrane dynamics of rat intestinal brush border membrane induced by different classes of nonsteroidal anti-inflammatory drugs. Toxicol Mech Methods 17:49-56.